115 related articles for article (PubMed ID: 16835273)
1. Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability.
Tatsumi Y; Sugimoto N; Yugawa T; Narisawa-Saito M; Kiyono T; Fujita M
J Cell Sci; 2006 Aug; 119(Pt 15):3128-40. PubMed ID: 16835273
[TBL] [Abstract][Full Text] [Related]
2. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
3. The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted.
Liu E; Lee AY; Chiba T; Olson E; Sun P; Wu X
J Cell Biol; 2007 Nov; 179(4):643-57. PubMed ID: 18025301
[TBL] [Abstract][Full Text] [Related]
4. The ATM-dependent DNA damage signaling pathway.
Kitagawa R; Kastan MB
Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
[TBL] [Abstract][Full Text] [Related]
5. Redundant and differential regulation of multiple licensing factors ensures prevention of re-replication in normal human cells.
Sugimoto N; Yoshida K; Tatsumi Y; Yugawa T; Narisawa-Saito M; Waga S; Kiyono T; Fujita M
J Cell Sci; 2009 Apr; 122(Pt 8):1184-91. PubMed ID: 19339550
[TBL] [Abstract][Full Text] [Related]
6. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
Denchi EL; de Lange T
Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
[TBL] [Abstract][Full Text] [Related]
7. DDB1 maintains genome integrity through regulation of Cdt1.
Lovejoy CA; Lock K; Yenamandra A; Cortez D
Mol Cell Biol; 2006 Nov; 26(21):7977-90. PubMed ID: 16940174
[TBL] [Abstract][Full Text] [Related]
8. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
Gibson SL; Bindra RS; Glazer PM
Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
[TBL] [Abstract][Full Text] [Related]
10. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
Huang SM; Lu KT; Wang YC
Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover.
Milhollen MA; Narayanan U; Soucy TA; Veiby PO; Smith PG; Amidon B
Cancer Res; 2011 Apr; 71(8):3042-51. PubMed ID: 21487042
[TBL] [Abstract][Full Text] [Related]
12. A p53-dependent checkpoint pathway prevents rereplication.
Vaziri C; Saxena S; Jeon Y; Lee C; Murata K; Machida Y; Wagle N; Hwang DS; Dutta A
Mol Cell; 2003 Apr; 11(4):997-1008. PubMed ID: 12718885
[TBL] [Abstract][Full Text] [Related]
13. SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.
Jo U; Murai Y; Chakka S; Chen L; Cheng K; Murai J; Saha LK; Miller Jenkins LM; Pommier Y
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536335
[TBL] [Abstract][Full Text] [Related]
14. Cdt1 and Cdc6 are destabilized by rereplication-induced DNA damage.
Hall JR; Lee HO; Bunker BD; Dorn ES; Rogers GC; Duronio RJ; Cook JG
J Biol Chem; 2008 Sep; 283(37):25356-25363. PubMed ID: 18617514
[TBL] [Abstract][Full Text] [Related]
15. Loss of Geminin induces rereplication in the presence of functional p53.
Melixetian M; Ballabeni A; Masiero L; Gasparini P; Zamponi R; Bartek J; Lukas J; Helin K
J Cell Biol; 2004 May; 165(4):473-82. PubMed ID: 15159417
[TBL] [Abstract][Full Text] [Related]
16. Impact of G₂ checkpoint defect on centromeric instability.
Deng W; Tsao SW; Mak GW; Tsang CM; Ching YP; Guan XY; Huen MS; Cheung AL
Oncogene; 2011 Mar; 30(11):1281-9. PubMed ID: 21057540
[TBL] [Abstract][Full Text] [Related]
17. Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells.
Fujita M
Cell Div; 2006 Oct; 1():22. PubMed ID: 17042960
[TBL] [Abstract][Full Text] [Related]
18. DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint.
Sansam CL; Shepard JL; Lai K; Ianari A; Danielian PS; Amsterdam A; Hopkins N; Lees JA
Genes Dev; 2006 Nov; 20(22):3117-29. PubMed ID: 17085480
[TBL] [Abstract][Full Text] [Related]
19. Origin licensing and p53 status regulate Cdk2 activity during G(1).
Nevis KR; Cordeiro-Stone M; Cook JG
Cell Cycle; 2009 Jun; 8(12):1952-63. PubMed ID: 19440053
[TBL] [Abstract][Full Text] [Related]
20. Cdt1 overexpression drives colorectal carcinogenesis through origin overlicensing and DNA damage.
Petropoulos M; Champeris Tsaniras S; Nikou S; Maxouri S; Dionellis VS; Kalogeropoulou A; Karamichali A; Ioannidis K; Danalatos IR; Obst M; Naumann R; Delinasios GJ; Gorgoulis VG; Roukos V; Anastassiadis K; Halazonetis TD; Bravou V; Lygerou Z; Taraviras S
J Pathol; 2023 Jan; 259(1):10-20. PubMed ID: 36210634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
